“No Cause for Alarm”: NCDC Officially Debunks Hantavirus Rumors in NigeriaV


The Nigeria Centre for Disease Control and Prevention (NCDC) has officially debunked rumors of Hantavirus cases in the country, following a wave of social media misinformation that suggested an outbreak had reached Nigerian shores.

In a public health advisory issued on Friday, May 8, 2026, the NCDC Director-General, Dr. Jide Idris, clarified that there is currently no evidence of Hantavirus infections within Nigeria.

The Global Context: The “Cruise Ship” Cluster

The NCDC’s advisory was triggered by international reports of a Hantavirus cluster linked to international cruise ship travel involving 147 passengers and crew members.

  • The Strain: The current international cases are linked to the Andes virus strain, which is native to South America.
  • The Risk Level: The World Health Organization (WHO) and NCDC have both stated that the risk to the general public remains low, as human-to-human transmission is extremely rare and typically requires very close contact.

Warning Against “Digital Misinformation”

The NCDC felt compelled to speak out after a verified social media user (claiming to be a medical professional) falsely posted that Nigeria had recorded its “2nd case” of the virus. The agency urged Nigerians to:

  • Rely on Verified Sources: Only trust health updates from the official NCDC website or social media handles.
  • Avoid Panic: The NCDC reminded the public that while Hantavirus can be severe, it is localized and rare compared to endemic issues like Lassa Fever.

Fact Sheet: What is Hantavirus?

FeatureDetails
TransmissionPrimarily through contact with infected rodents (saliva, urine, or droppings) or inhaling contaminated dust particles.
SymptomsFatigue, fever, muscle aches, and gastrointestinal issues. Severe cases can lead to pneumonia or respiratory failure.
PreventionRodent control, proper food storage, and avoiding the cleaning of rodent-infested areas without protective gear.
TreatmentNo specific vaccine exists; treatment focuses on managing symptoms and respiratory support in a hospital setting.